SMART ARTIFICIAL PANCREAS MARKET

INTRODUCTION

 An artificial pancreas is a three-part device that mimics how a healthy pancreas regulates blood glucose, also known as blood sugar, in the body. People with type 1 diabetes are typically helped by a prosthetic pancreas.

 The pancreas does not generate insulin when a person has type 1 diabetes. People with type 1 diabetes manage their blood sugar levels by monitoring them and administering insulin several times per day via injection or insulin infusion device. 

SMART ARTIFICIAL PANCREAS MARKET SIZE AND FORECAST

The Global Smart Artificial Pancreas market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

SMART ARTIFICIAL PANCREAS MARKET NEW PRODUCT LAUNCH

The artificial pancreas device will be launched in Europe by Abbott's diabetes team-up with Ypsomed and CamDiab.

These blood sugar readings will be sent to an intelligent insulin pump from Ypsomed and a mobile app created by CamDiab, a spinoff company from the University of Cambridge that recently showed how its artificial pancreas software could help manage Type 1 diabetes in toddlers and young children. 

The CamAPS FX, which is already approved in Europe, is a highly adaptive algorithm that when combined with Abbott's sensor is being designed to communicate with Ypsomed's insulin pump to provide the optimal insulin dose, lessening the burden of managing a condition that is relentlessly unpredictable day and night.

The CamAPS FX self-learning app is a hybrid, closed-loop system that works with users as young as one year old and operates on an Android smartphone.

 CamDiab has been working with Ypsomed to connect the software with its mylife YpsoPump system while depending on information from Dexcom's G6 continuous glucose monitor to adjust insulin doses and assist in preventing blood sugar levels from falling too low or rising too high.

Results from a randomised clinical study were presented by CamDiab, demonstrating that participants spent an extra two hours per day on average with stable levels and that more than 70% of children were able to go 24 hours without their glucose readings leaving a healthy range.

SMART ARTIFICIAL PANCREAS MARKET COMPANY PROFILES

• Tracxn
• Fierce Biotech
• Dia Tribe
• BMJ
• Labiotech

THIS SMART ARTIFICIAL PANCREAS MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many Smart Artificial Pancreas are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global Smart Artificial Pancreas and key vendor selection criteria
3. Where is the Smart Artificial Pancreas manufactured? What is the average margin per unit?
4. Market share of Global Smart Artificial Pancreas market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global Smart Artificial Pancreas in-house
6. key predictions for next 5 years in Global Smart Artificial Pancreas market
7. Average B-2-B Smart Artificial Pancreas market price in all segments
8. Latest trends in Smart Artificial Pancreas market, by every market segment
9. The market size (both volume and value) of the Smart Artificial Pancreas market in 2024-2030 and every year in between?
10. Production breakup of Smart Artificial Pancreas market, by suppliers and their OEM relationship